tiprankstipranks
Sanuwave Health (SNWV)
NASDAQ:SNWV
US Market
SNWV
Sanuwave Health
RESEARCH TOOLSreports
Want to see SNWV full AI Analyst Report?

Sanuwave Health (SNWV) Ratios

53 Followers

Sanuwave Health Ratios

SNWV's free cash flow for Q4 2025 was $0.69. For the 2025 fiscal year, SNWV's free cash flow was decreased by $ and operating cash flow was $-0.47. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Mar 23
Liquidity Ratios
Current Ratio
 1.38 1.38 0.43 0.15 0.11
Quick Ratio
 1.05 1.05 0.34 0.11 0.10
Cash Ratio
 0.67 0.67 0.24 0.03 0.02
Solvency Ratio
 0.37 0.37 -0.71 -0.38 -0.15
Operating Cash Flow Ratio
 0.22 0.22 0.06 -0.07 -0.29
Short-Term Operating Cash Flow Coverage
 0.67 0.67 0.10 -0.15 -0.45
Net Current Asset Value
$ -11.10M$ -11.10M$ -24.44M$ -55.81M$ -54.26M
Leverage Ratios
Debt-to-Assets Ratio
 0.62 0.62 0.85 1.36 1.96
Debt-to-Equity Ratio
 14.19 14.19 -2.00 -0.71 -0.95
Debt-to-Capital Ratio
 0.93 0.93 2.00 -2.39 -19.16
Long-Term Debt-to-Capital Ratio
 0.91 0.91 0.00 0.00 0.00
Financial Leverage Ratio
 23.07 23.07 -2.37 -0.52 -0.48
Debt Service Coverage Ratio
 0.51 0.51 -0.43 -0.20 0.09
Interest Coverage Ratio
 0.79 0.79 0.40 -0.03 -0.63
Debt to Market Cap
 0.16 0.09 0.25 2.91 3.08
Interest Debt Per Share
 3.41 3.41 8.77 21.77 36.24
Net Debt to EBITDA
 1.77 1.77 -0.92 -3.13 7.89
Profitability Margins
Gross Profit Margin
75.12%75.12%75.23%70.41%74.13%
EBIT Margin
11.23%11.23%-54.26%-49.91%22.94%
EBITDA Margin
14.14%14.14%-50.75%-44.87%28.63%
Operating Profit Margin
11.23%11.23%16.60%-2.65%-53.47%
Pretax Profit Margin
27.01%27.01%-96.05%-126.50%-61.47%
Net Profit Margin
26.82%26.82%-96.13%-126.52%-61.48%
Continuous Operations Profit Margin
26.82%26.82%-96.13%-126.52%-61.48%
Net Income Per EBT
99.28%99.28%100.09%100.02%100.02%
EBT Per EBIT
240.63%240.63%-578.64%4778.33%114.96%
Return on Assets (ROA)
31.63%31.63%-104.16%-115.13%-51.79%
Return on Equity (ROE)
-141.56%729.65%246.69%59.77%25.10%
Return on Capital Employed (ROCE)
25.36%25.36%-44.31%1.28%22.19%
Return on Invested Capital (ROIC)
19.41%19.41%41.42%4.36%496.23%
Return on Tangible Assets
43.66%43.66%-164.00%-240.69%-137.68%
Earnings Yield
8.30%4.62%-30.56%-250.32%-82.16%
Efficiency Ratios
Receivables Turnover
 8.12 8.12 9.80 6.16 4.16
Payables Turnover
 3.37 3.37 2.17 1.06 0.98
Inventory Turnover
 1.85 1.85 1.95 2.05 4.99
Fixed Asset Turnover
 18.65 18.65 44.58 21.75 19.56
Asset Turnover
 1.18 1.18 1.08 0.91 0.84
Working Capital Turnover Ratio
 8.96 -5.13 -0.83 -0.38 -0.32
Cash Conversion Cycle
 134.26 134.26 56.24 -107.26 -209.83
Days of Sales Outstanding
 44.93 44.93 37.23 59.30 87.84
Days of Inventory Outstanding
 197.58 197.58 187.33 178.48 73.15
Days of Payables Outstanding
 108.25 108.25 168.32 345.04 370.82
Operating Cycle
 242.51 242.51 224.56 237.78 160.99
Cash Flow Ratios
Operating Cash Flow Per Share
 0.45 0.45 0.55 -2.14 -11.72
Free Cash Flow Per Share
 0.45 0.23 0.44 -2.14 -11.02
CapEx Per Share
 0.00 0.23 0.11 0.00 0.70
Free Cash Flow to Operating Cash Flow
 1.00 0.50 0.80 1.00 0.94
Dividend Paid and CapEx Coverage Ratio
 0.00 2.00 5.01 0.00 -16.80
Capital Expenditure Coverage Ratio
 0.00 2.00 5.01 0.00 -16.80
Operating Cash Flow Coverage Ratio
 0.17 0.17 0.10 -0.15 -0.44
Operating Cash Flow to Sales Ratio
 0.09 0.09 0.08 -0.22 -1.03
Free Cash Flow Yield
2.72%0.76%1.91%-44.02%-128.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.40 21.63 -3.27 -0.40 -1.22
Price-to-Sales (P/S) Ratio
 3.07 5.80 3.15 0.51 0.75
Price-to-Book (P/B) Ratio
 83.20 157.84 -8.07 -0.24 -0.31
Price-to-Free Cash Flow (P/FCF) Ratio
 34.88 132.13 52.24 -2.27 -0.78
Price-to-Operating Cash Flow Ratio
 34.75 65.93 41.81 -2.27 -0.73
Price-to-Earnings Growth (PEG) Ratio
 0.05 -0.18 0.08 >-0.01 0.02
Price-to-Fair Value
 83.20 157.84 -8.07 -0.24 -0.31
Enterprise Value Multiple
 23.47 42.80 -7.12 -4.26 10.51
Enterprise Value
 153.76M 266.55M 117.91M 38.97M 50.35M
EV to EBITDA
 24.69 42.80 -7.12 -4.26 10.51
EV to Sales
 3.49 6.05 3.61 1.91 3.01
EV to Free Cash Flow
 39.67 137.82 60.00 -8.59 -3.12
EV to Operating Cash Flow
 39.67 68.77 48.03 -8.59 -2.93
Tangible Book Value Per Share
 -1.01 -1.01 -5.31 -25.92 -36.45
Shareholders’ Equity Per Share
 0.19 0.19 -2.85 -20.40 -27.99
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 5.14 5.14 7.31 9.64 11.43
Net Income Per Share
 1.38 1.38 -7.03 -12.19 -7.02
Tax Burden
 0.99 0.99 1.00 1.00 1.00
Interest Burden
 2.41 2.41 1.77 2.53 -2.68
Research & Development to Revenue
 0.03 0.03 0.02 0.03 0.03
SG&A to Revenue
 0.61 0.61 0.54 0.43 0.75
Stock-Based Compensation to Revenue
 -0.03 0.00 0.05 0.00 0.00
Income Quality
 0.00 0.00 -0.08 0.18 1.67
Currency in USD